XOMA Corporation

NASDAQ XOMAO

Download Data

XOMA Corporation Non-current Liabilities to Total Liabilities Ratio for the Trailing 12 Months (TTM) ending March 31, 2024: 0.89

XOMA Corporation Non-current Liabilities to Total Liabilities Ratio is 0.89 for the Trailing 12 Months (TTM) ending March 31, 2024, a 67.92% change year over year. The total non-current liabilities to total liabilities ratio measures the proportion of a company's non-current liabilities to its total liabilities. It is calculated by dividing the total non-current liabilities by the total liabilities. This ratio provides insights into the composition of a company's liabilities and the extent to which it relies on long-term debt and obligations. A higher ratio indicates a greater reliance on non-current liabilities, suggesting potential long-term financial commitments and increased financial risk.
  • XOMA Corporation Non-current Liabilities to Total Liabilities Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 0.53.
NASDAQ: XOMAO

XOMA Corporation

CEO -
IPO Date April 12, 2021
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAP

XOMA Corp

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email